3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
37
INDUSTRY
4
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
196
Neoplasms
104
Colorectal Neoplasms
91
Stomach Neoplasms
80
Uterine Cervical Neoplasms
70
Carcinoma, Non-Small-Cell Lung
67
Carcinoma, Hepatocellular
53
Lung Neoplasms
48
Prostatic Neoplasms
47
Rectal Neoplasms
46
Esophageal Neoplasms
39
Pancreatic Neoplasms
37
Colonic Neoplasms
36
Ovarian Neoplasms
35
Recurrence
33
Head and Neck Neoplasms
33
Neoplasm Metastasis
28
Motor Activity
28
Multiple Myeloma
27
Small Cell Lung Carcinoma
26
Melanoma
25
Polycystic Ovary Syndrome
24
Lymphoma, Non-Hodgkin
24
Lymphoma
24
Leukemia, Myeloid, Acute
21
Precursor Cell Lymphoblastic Leukemia-Lymphoma
20
Pain
20
Brain Neoplasms
20
Nasopharyngeal Carcinoma
18
Hematologic Neoplasms
17
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Interventional
×
Medication Adherence
×
Clear all
NCT05324020
2023-09-07
Edherence
Luxembourg Institute of Health
Phase NA
Completed
3 enrolled